FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Christophe Desvignes

Research Profile

Procedures

Microdialysis

Living Beings

Chemicals & Drugs

Co-author Network

Publications

TOP 3
Yves Claustre; Liliane Rouquier; Christophe Desvignes; Maud Leonetti; J Montégut; N Aubin; Nathalie Allouard; Isabelle Bougault; Florence Oury-Donat; Régis Steinberg
Effects of the vasopressin (V1b) receptor antagonist, SSR149415, and the corticotropin-releasing factor 1 receptor antagonist, SSR125543, on FG 7142-induced increase in acetylcholine and norepinephrine release in the rat.
Maud Leonetti; Christophe Desvignes; Isabelle Bougault; J Souilhac; Florence Oury-Donat; Régis Steinberg
2-Chloro-N-[(S)-phenyl [(2S)-piperidin-2-yl] methyl]-3-trifluoromethyl benzamide, monohydrochloride, an inhibitor of the glycine transporter type 1, increases evoked-dopamine release in the rat nucleus accumbens in vivo via an enhanced glutamatergic neurotransmission.
Ronan Depoortère; Gihad Dargazanli; Genevieve Estenne-Bouhtou; Annick Coste; Christophe Lanneau; Christophe Desvignes; Martine Poncelet; Michel Heaulme; Vincent Santucci; Michel Decobert; Annie Cudennec; Carolle Voltz; Denis Boulay; Jean-Paul Terranova; Jeanne Stemmelin; Pierre Roger; Benoit Marabout; Mireille Sevrin; Xavier Vigé; Bruno Biton; Régis Steinberg; Dominique Françon; Richard Alonso; Patrick Avenet; Florence Oury-Donat; Ghislaine Perrault; Guy Griebel; Pascal Guy GEORGE; Philippe Soubrié; Bernard Scatton
Neurochemical, electrophysiological and pharmacological profiles of the selective inhibitor of the glycine transporter-1 SSR504734, a potential new type of antipsychotic.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Christophe Desvignes (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2006: Yves Claustre; Liliane Rouquier; Christophe Desvignes; Maud Leonetti; J Montégut; N Aubin; Nathalie Allouard; Isabelle Bougault; Florence Oury-Donat; Régis Steinberg
Effects of the vasopressin (V1b) receptor antagonist, SSR149415, and the corticotropin-releasing factor 1 receptor antagonist, SSR125543, on FG 7142-induced increase in acetylcholine and norepinephrine release in the rat.
Neuroscience 2006;141(3):1481-8.
2006: Maud Leonetti; Christophe Desvignes; Isabelle Bougault; J Souilhac; Florence Oury-Donat; Régis Steinberg
2-Chloro-N-[(S)-phenyl [(2S)-piperidin-2-yl] methyl]-3-trifluoromethyl benzamide, monohydrochloride, an inhibitor of the glycine transporter type 1, increases evoked-dopamine release in the rat nucleus accumbens in vivo via an enhanced glutamatergic neurotransmission.
Neuroscience 2006;137(2):555-64.
2005: Ronan Depoortère; Gihad Dargazanli; Genevieve Estenne-Bouhtou; Annick Coste; Christophe Lanneau; Christophe Desvignes; Martine Poncelet; Michel Heaulme; Vincent Santucci; Michel Decobert; Annie Cudennec; Carolle Voltz; Denis Boulay; Jean-Paul Terranova; Jeanne Stemmelin; Pierre Roger; Benoit Marabout; Mireille Sevrin; Xavier Vigé; Bruno Biton; Régis Steinberg; Dominique Françon; Richard Alonso; Patrick Avenet; Florence Oury-Donat; Ghislaine Perrault; Guy Griebel; Pascal Guy GEORGE; Philippe Soubrié; Bernard Scatton
Neurochemical, electrophysiological and pharmacological profiles of the selective inhibitor of the glycine transporter-1 SSR504734, a potential new type of antipsychotic.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2005;30(11):1963-85.
2003: Christophe Desvignes; Liliane Rouquier; J Souilhac; G Mons; Daniel Rodier; Philippe Soubrié; Régis Steinberg
Control by tachykinin NK(2) receptors of CRF(1) receptor-mediated activation of hippocampal acetylcholine release in the rat and guinea-pig.
Neuropeptides 2003;37(2):89-97.
2002: Régis Steinberg; Richard Alonso; Liliane Rouquier; Christophe Desvignes; Jean-Claude Michaud; Annie Cudennec; Mireille Jung; Jacques Simiand; Guy Griebel; Xavier Emonds-Alt; Gérard Le-Fur; Philippe Soubrié
SSR240600 [(R)-2-(1-[2-[4-[2-[3,5-bis(trifluoromethyl)phenyl]acetyl]-2-(3,4-dichlorophenyl)-2-morpholinyl]ethyl]-4-piperidinyl)-2-methylpropanamide], a centrally active nonpeptide antagonist of the tachykinin neurokinin 1 receptor: II. Neurochemical and behavioral characterization.
The Journal of pharmacology and experimental therapeutics 2002;303(3):1180-8.
2002: Lionel Bert; Sandrine Parrot; Frédéric Robert; Christophe Desvignes; Luc Denoroy; Marie-Françoise Suaud-Chagny; Bernard Renaud
In vivo temporal sequence of rat striatal glutamate, aspartate and dopamine efflux during apomorphine, nomifensine, NMDA and PDC in situ administration.
Neuropharmacology 2002;43(5):825-35.
2001: Régis Steinberg; Richard Alonso; Guy Griebel; Lionel Bert; Mireille Jung; Florence Oury-Donat; Martine Poncelet; Christiane Gueudet; Christophe Desvignes; Gérard Le-Fur; Philippe Soubrié
Selective blockade of neurokinin-2 receptors produces antidepressant-like effects associated with reduced corticotropin-releasing factor function.
The Journal of pharmacology and experimental therapeutics 2001;299(2):449-58.
1999: Christophe Desvignes; Lionel Bert; L Vinet; Luc Denoroy; Bernard Renaud; Laura Lambás-Señas
Evidence that the neuronal nitric oxide synthase inhibitor 7-nitroindazole inhibits monoamine oxidase in the rat: in vivo effects on extracellular striatal dopamine and 3,4-dihydroxyphenylacetic acid.
Neuroscience letters 1999;264(1-3):5-8.
1999: Christophe Desvignes; Lionel Bert; L Vinet; Luc Denoroy; Bernard Renaud; Laura Lambás-Señas
Evidence that the neuronal nitric oxide synthase inhibitor 7-nitroindazole inhibits monoamine oxidase in the rat: in vivo effects on extracellular striatal dopamine and 3,4-dihydroxyphenylacetic acid.
Neuroscience letters 1999;261(3):175-8.
1997: Christophe Desvignes; Frédéric Robert; C Vachette; Guy Chouvet; R Cespuglio; Bernard Renaud; Laura Lambás-Señas
Monitoring nitric oxide (NO) in rat locus coeruleus: differential effects of NO synthase inhibitors.
Neuroreport 1997;8(6):1321-5.
1996: Christophe Desvignes; H Bour; Jean-François Nicolas; Dominique Kaiserlian
Lack of oral tolerance but oral priming for contact sensitivity to dinitrofluorobenzene in major histocompatibility complex class II-deficient mice and in CD4+ T cell-depleted mice.
European journal of immunology 1996;26(8):1756-61.
1995: H Bour; E Peyron; M Gaucherand; J L Garrigue; Christophe Desvignes; Dominique Kaiserlian; Jean-Pierre Revillard; Jean-François Nicolas
Major histocompatibility complex class I-restricted CD8+ T cells and class II-restricted CD4+ T cells, respectively, mediate and regulate contact sensitivity to dinitrofluorobenzene.
European journal of immunology 1995;25(11):3006-10.
1995: V Galliaerde; Christophe Desvignes; E Peyron; Dominique Kaiserlian
Oral tolerance to haptens: intestinal epithelial cells from 2,4-dinitrochlorobenzene-fed mice inhibit hapten-specific T cell activation in vitro.
European journal of immunology 1995;25(5):1385-90.